Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
暂无分享,去创建一个
Richard W. Martin | M. Mayes | P. Merkel | D. Furst | R. Simms | T. Medsger | J. Korn | J. Seibold | D. Collier | M. Csuka | S. Jimenez | P. Bell | B. White | Jennifer J. Anderson | F. Wigley | K. Herlyn | A. Weinstein | N. Rothfield | M. Ellman | P. Merkel
[1] A. Blann,et al. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. , 1999, Arthritis and rheumatism.
[2] M. Mayes,et al. Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. , 1999, Arthritis and rheumatism.
[3] P. Merkel,et al. Measurement of functional status, self-assessment, and psychological well-being in scleroderma. , 1998, Current opinion in rheumatology.
[4] Richard W. Martin,et al. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. , 1998, Arthritis and rheumatism.
[5] T. Medsger,et al. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. , 1997, Arthritis and rheumatism.
[6] R. Roca,et al. Depressive symptoms associated with scleroderma. , 1996, Arthritis and rheumatism.
[7] V. Malcarne,et al. Psychological adjustment to systemic sclerosis. , 1996, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[8] J. Poole,et al. Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma. , 1995, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[9] L. Kaufman,et al. Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study , 1994, Annals of Internal Medicine.
[10] A. Silman,et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. , 1993, The Journal of rheumatology.
[11] D. Moser,et al. Predictors of psychosocial adjustment in systemic sclerosis , 1993 .
[12] F. Wolfe,et al. Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. , 1992, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[13] J. Poole,et al. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. , 1991, Arthritis care and research : the official journal of the Arthritis Health Professions Association.
[14] Lewis E. Kazis,et al. Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.
[15] T. Pincus,et al. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. , 1989, Annals of internal medicine.
[16] M. Hochberg,et al. Physical disability and psychosocial dysfunction in systemic lupus erythematosus. , 1988, The Journal of rheumatology.
[17] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[18] M H Liang,et al. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. , 1985, Arthritis and rheumatism.
[19] P. Tugwell,et al. A methodologic framework for developing and selecting endpoints in clinical trials. , 1982, The Journal of rheumatology.
[20] J. Fries,et al. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. , 1982, The Journal of rheumatology.
[21] A. Masi. Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.
[22] James F. Fries,et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.
[23] D. Kleinbaum,et al. Applied Regression Analysis and Other Multivariate Methods , 1978 .
[24] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[25] D. Moser,et al. Predictors of psychosocial adjustment in systemic sclerosis. The influence of formal education level, functional ability, hardiness, uncertainty, and social support. , 1993, Arthritis and rheumatism.
[26] L. Kazis,et al. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. , 1992, Arthritis and rheumatism.
[27] P. Gertman,et al. Measuring health status in arthritis. The arthritis impact measurement scales. , 1980, Arthritis and rheumatism.
[28] H. Holman,et al. Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.
[29] Jae-On Kim,et al. Factor Analysis: Statistical Methods and Practical Issues , 1978 .